Get my own profile
Public access
View all41 articles
7 articles
available
not available
Based on funding mandates
Co-authors
Thomas TütingDepartment of Dermatology, University Hospital Magdeburg, GermanyVerified email at med.ovgu.de
Michael HolzelInstitute of Experimental Oncology, University Hospital Bonn, Germany. Twitter: @IEO_HolzelLabVerified email at ukb.uni-bonn.de
Mark J. SmythQIMR BerghoferVerified email at qimrberghofer.edu.au
Nicole GloddeInstitute of Experimental Oncology, University Hospital Bonn. Twitter: IEO_GloddeLabVerified email at ukbonn.de
Michele WL TengQIMR Berghofer MRIVerified email at qimrberghofer.edu.au
Kyohei Nakamura M.D., Ph.D.Team Head, QIMR Berghofer Medical Research InstituteVerified email at qimrberghofer.edu.au
Göran JönssonProfessor, Dept. of Oncology, Clinical Sciences, Lund University, SwedenVerified email at med.lu.se
Jasmin StraubeQIMR Berghofer Medical Research InstituteVerified email at qimrberghofer.edu.au
Veit HornungGene Center and Department of Biochemistry, Ludwig-Maximilians-University MunichVerified email at genzentrum.lmu.de
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Royal Prince Alfred HospitalVerified email at sswahs.nsw.gov.au
Georgina V LongMelanoma Institute Australia, The University of Sydney and Royal North Shore HospitalVerified email at sydney.edu.au
Ulrich KalinkeInstitute for Experimental Infection Research, TWINCORE, Centre for Experimental and ClinicalVerified email at twincore.de
Winfried BarchetIFM Therapeutics, Executive Director Innate ImmunityVerified email at ifmthera.com
Nicola WaddellQIMR Berghofer Medical Research InstituteVerified email at qimrberghofer.edu.au